secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2026-06-16T20:00:51+00:00
Accession:  0001731122-26-000865
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Lunai Bioworks regains Nasdaq minimum bid price compliance; faces 1-year monitoring
--------------------------------------------------------------------------------

- Nasdaq confirmed Lunai Bioworks regained compliance with $1.00 minimum bid price rule (Rule 5550(a)(2)).
- Company met terms set by Nasdaq Hearings Panel decisions dated April 20, 2026 and May 12, 2026.
- Mandatory Panel monitor imposed for one year; no compliance plan or cure period if bid price drops again.
- If non-compliant during monitor, Nasdaq will issue delist determination; company may request new hearing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112226000865/0001731122-26-000865-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112226000865/e7720_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-26-000865

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer